· 2 min read
illuminem summarises for you the essential news of the day. Read the full piece on Wired or enjoy below:
🗞️ Driving the news: Biotech startup Manhattan Genomics is reigniting controversy by proposing to edit human embryos to prevent inherited diseases
• The company aims to use CRISPR-based technologies to create embryos free of genetic conditions — potentially leading to pregnancies, echoing the globally condemned 2018 experiment by Chinese scientist He Jiankui
🔭 The context: He Jiankui’s unauthorized gene-editing of human embryos in 2018 sparked international outrage, resulting in his prison sentence and widespread calls for tighter global bioethics oversight
• Since then, global consensus has moved toward a cautious, regulated approach to human germline editing, particularly due to safety, ethical, and societal implications
•Manhattan Genomics is entering a deeply sensitive scientific and regulatory landscape
🌍 Why it matters for the planet: Gene-editing human embryos has profound implications for health equity, biodiversity, and long-term sustainability of the human genome
• While eliminating certain heritable diseases could reduce long-term healthcare burdens and improve quality of life, the risks of unintended mutations, ethical misuse, and access inequality raise serious concerns
• It challenges the principle of responsible innovation in biotechnology and global standards for human dignity and environmental responsibility
⏭️ What's next: Manhattan Genomics faces major regulatory hurdles in the U.S. and abroad, as germline editing for reproduction is currently banned or heavily restricted in most countries
• The startup’s progress will likely depend on legal reinterpretation, public discourse, and scientific transparency
• International bodies such as the WHO and national ethics panels are expected to respond if trials are proposed, potentially reshaping global bioethics frameworks in the next few years
💬 One quote: “Once you start editing embryos, you’re not just treating a patient — you’re changing the human species,” — Hank Greely, professor of law and bioethics at Stanford University
📈 One stat: As of 2023, over 75 countries have formal bans or restrictions on heritable human genome editing for reproductive purposes
Explore carbon credit purchases, total emissions, and climate targets of thousands of companies on Data Hub™ — the first platform designed to help sustainability providers generate sales leads!
Click for more news covering the latest on sustainable business
